Weinheimer Kent, Patrick Nathan, Darowish Michael
1 Penn State Health Milton S. Hershey Medical Center, Hershey, PA, USA.
Hand (N Y). 2019 May;14(3):381-385. doi: 10.1177/1558944717744336. Epub 2017 Dec 14.
Various options exist for operative and nonoperative treatment of symptomatic distal interphalangeal (DIP) ganglion cysts. We describe the technique and efficacy of a novel treatment of DIP ganglion cysts using a volar, transtendon, intra-articular injection of corticosteroid.
This was a single center, retrospective study (2010-2015) of 21 patients who received a volar, intra-articular corticosteroid injection for treatment of DIP ganglion cysts. The patients were contacted via mailing with a short survey. For those potential study participants who did not respond to the mailing or were not seen in follow-up, contact was made via telephone. The primary study outcome was resolution of the cyst; secondary outcomes included pain and postinjection complications.
A total of 21 patients (14 female; 7 male) with 23 DIP ganglion cysts were treated in this study. The dominant hand was involved in 56.5% cases. Twelve (52.2%) resolved or had near complete resolution following injection at an average follow-up of 20 months.
For patients with DIP ganglion cysts, this newly described technique of volar, transtendon, intra-articular injection of corticosteroid provides a safe and effective treatment. This technique allows for ease and consistency of needle placement for intra-articular corticosteroid delivery while minimizing the potential soft tissue and infection concerns described with other techniques.
对于有症状的远侧指间关节（DIP）腱鞘囊肿，存在多种手术和非手术治疗选择。我们描述了一种使用掌侧经肌腱关节内注射皮质类固醇治疗DIP腱鞘囊肿的新技术及其疗效。
这是一项单中心回顾性研究（2010 - 2015年），研究对象为21例接受掌侧关节内皮质类固醇注射治疗DIP腱鞘囊肿的患者。通过邮寄简短调查问卷与患者取得联系。对于那些未回复邮件或未在随访中就诊的潜在研究参与者，通过电话进行联系。主要研究结果是囊肿消退；次要结果包括疼痛和注射后并发症。
本研究共治疗了21例患者（14例女性；7例男性），共23个DIP腱鞘囊肿。优势手受累的病例占56.5%。在平均20个月的随访中，12例（52.2%）在注射后囊肿消退或接近完全消退。
对于DIP腱鞘囊肿患者，这种新描述的掌侧经肌腱关节内注射皮质类固醇技术提供了一种安全有效的治疗方法。该技术便于关节内皮质类固醇注射时针头放置的简便性和一致性，同时将其他技术中潜在的软组织和感染问题降至最低。
